Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vor Biopharma Inc.

0.6791
-0.0008-0.12%
Pre-market: 0.73000.0509+7.50%08:00 EDT
Volume:175.53K
Turnover:118.69K
Market Cap:84.79M
PE:-0.40
High:0.6994
Open:0.6870
Low:0.6601
Close:0.6799
Loading ...
Jul 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 10, 2024

Major Issues Report

Form 8-K - Current report
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 28, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2024

Major Issues Report

Form 8-K - Current report
Mar 21, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 20, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Aug 30, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 12, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
May 27, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2023

Major Issues Report

8-K - Current report